ArticleScandinavian journal of public health2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study.
Abstract read
In one paragraph
Article in Scandinavian journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pooled it
- Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis.The Lancet. Global health · 2021Pooled it
- Work-Related Exposures Mediate Occupational Class Disparities in SARS-CoV-2 Infection in France.International journal of public health · 2026Article
- Factors associated with severe acute respiratory syndrome coronavirus-2 infection in Hohoe Municipality, Ghana: A case-control study.PloS one · 2026Article
- Antibody Kinetics of Immunological Memory in SARS-CoV-2-Vaccinated Healthcare Workers-The ORCHESTRA Project.Vaccines · 2025Article
- Social inequalities in SARS-CoV-2 infection in high income countries: highlighting the need for an intersectional perspective in quantitative research.Frontiers in public health · 2025Review
- Transmission matrix parameter estimation of COVID-19 evolution with age compartments using ensemble-based data assimilation.PloS one · 2025Article
- National and sub-national sero-epidemiology of immunoglobulin G against SARS-CoV-2 in Iran in 2021.PloS one · 2025Article
- Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario.Canadian journal of public health = Revue canadienne de sante publique · 2024Article
- Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study.Microbiology spectrum · 2024Article
- Seroprevalence of Anti-SARS-CoV-2 Remained Extremely Low in Taiwan Until the Vaccination Program Was Implemented.Open forum infectious diseases · 2024Article
- Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study.Nature communications · 2023Article
- Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study.Infection · 2023Article
- Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic.PloS one · 2023Article
- Higher Infection Risk among Health Care Workers and Lower Risk among Smokers Persistent across SARS-CoV-2 Waves-Longitudinal Results from the Population-Based TiKoCo Seroprevalence Study.International journal of environmental research and public health · 2022Article
- Associations between Depression and Self-Reported COVID-19 Symptoms among Adults: Results from Two Population-Based Seroprevalence Studies in Switzerland.International journal of environmental research and public health · 2022Article
- A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents.Nature communications · 2022Article
- Tobacco use and risk of COVID-19 infection in the Finnish general population.Scientific reports · 2022Article
- The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey.Internal and emergency medicine · 2022Article
- The association between micronutrients and the SARS-CoV-2-specific antibodies in convalescent patients.Infection · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Aude RichardDivision of Primary Care, Geneva University Hospitals, Switzerland.ORCID https://orcid.org/0000-0002-7379-402X
Ania WisniakDivision of Primary Care, Geneva University Hospitals, Switzerland.
Javier Perez-SaezInstitute of Global Health, University of Geneva, Switzerland.
Henri Garrison-DesanyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA.ORCID https://orcid.org/0000-0003-4164-7065
Dusan PetrovicDivision of Primary Care, Geneva University Hospitals, Switzerland.
Giovanni PiumattiDivision of Primary Care, Geneva University Hospitals, Switzerland.
Hélène BayssonDivision of Primary Care, Geneva University Hospitals, Switzerland.
Attilio PicazioDivision of Primary Care, Geneva University Hospitals, Switzerland.
Francesco PennacchioDivision of Primary Care, Geneva University Hospitals, Switzerland.
David De RidderDivision of Primary Care, Geneva University Hospitals, Switzerland.
François ChappuisDepartment of Health and Community Medicine, University of Geneva, Switzerland.
Nicolas VuilleumierDivision of Laboratory Medicine, Geneva University Hospitals, Switzerland.
Nicola LowInstitute of Social and Preventive Medicine, University of Bern, Switzerland.
Samia HurstInstitute for Ethics, History, and the Humanities, University of Geneva, Switzerland.
Isabella EckerleGeneva Center for Emerging Viral Diseases and Laboratory of Virology, Geneva University Hospitals, Switzerland.
Antoine FlahaultInstitute of Global Health, University of Geneva, Switzerland.
Laurent KaiserDepartment of Medicine, University of Geneva, Switzerland.
Andrew S AzmanInstitute of Global Health, University of Geneva, Switzerland.
Idris GuessousDivision of Primary Care, Geneva University Hospitals, Switzerland.
Silvia StringhiniDivision of Primary Care, Geneva University Hospitals, Switzerland.
Funding
Estimating Cholera Burden with Cross-sectional Immunologic DataR01AI135115 · NIAID · UNIVERSITY OF UTAH · PI LEUNG, DANIEL TED · 2018 to 2022
$3.4MNIAID NIH HHS R01 AI135115
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19SARS-CoV-2AdultAgedBayes TheoremChildChild, PreschoolFemaleHumansImmunoglobulin GMaleMiddle AgedRisk FactorsSeroepidemiologic StudiesSwitzerlandYoung AdultImmunoglobulin GCOVID-19population-based surveySARS-CoV-2seroprevalencesocioeconomic risk factors
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.